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ABSTRACT
Antiviral RNA-mediated silencing (RNA interference [RNAi]) acts as a powerful innate immunity defense in plants, inverte-
brates, and mammals. In Caenorhabditis elegans, RNAi is systemic; i.e., RNAi silencing signals can move between cells and tis-
sues. Furthermore, RNAi effects can be inherited transgenerationally andmay last for many generations. Neither the biological
relevance of systemic RNAi nor transgenerational RNAi is currently understood. Here we examined the role of both pathways in
the protection of C. elegans from viral infection. We studied the Orsay virus, a positive-strand RNA virus related toNodaviridae
and the first and only virus known to infect C. elegans. Immunity to Orsay virus infection requires the RNAi pathway. Surpris-
ingly, we found that genes required for systemic or transgenerational RNAi did not have a role in antiviral defense. Furthermore,
we found that Orsay virus infection did not elicit a systemic RNAi response even when a target for RNAi was provided by using
transgenes. Finally, we show that viral siRNAs, the effectors of RNAi, are not inherited to a level that provides any significant
resistance to viral infection in the next generation. We conclude that systemic or transgenerational RNAi does not play a role in
the defense against natural Orsay virus infection. Furthermore, our data suggest that there is a qualitative difference between
experimental RNAi and antiviral RNAi. Our data are consistent with a model of systemic and transgenerational RNAi that re-
quires a nuclear or germ line component that is lacking in almost all RNA virus infections.
IMPORTANCE
Since its discovery in Caenorhabditis elegans, RNAi has proven a valuable scientific tool in many organisms. In C. elegans, exog-
enous RNAi spreads throughout the organism and can be passed between generations; however, there has been controversy as to
the endogenous role(s) that the RNAi pathway plays. One endogenous role for which spreading both within the infected organ-
ism and between generations would be advantageous is a role in viral defense. In plants, antiviral RNAi is systemic and the
spread of RNAi between cells provides protection against subsequent viral infection. Here we investigated this by using the only
naturally occurring virus known to infect C. elegans, Orsay virus, and surprisingly found that, in contrast to the exogenous
RNAi pathway, the antiviral RNAi response targeted against this virus does not spread systemically throughout the organism
and cannot be passed between generations. These results suggest that there are differences between the two pathways that re-
main to be discovered.
RNA interference (RNAi) is a mechanism of gene silencing thatis broadly conserved across eukaryotes. RNAi is initiated by
the cleavage of long double-stranded RNA (dsRNA) by the RNase
III enzyme Dicer into short 20- to 24-nucleotide (nt) small inter-
fering RNAs (siRNAs) (1). These siRNAs are bound by Argonaute
proteins and act as a guide to the complementarymRNA, which is
subsequently destroyed by the slicer action of the Argonaute pro-
tein (2).
In Caenorhabditis elegans, there is an additional amplification
step in the pathway. siRNAs generated by Dicer (DCR-1) form
complexes with Argonaute proteins that recruit RNA-dependent
RNA polymerases (RdRps) to the target mRNA. The RdRps pro-
duce an abundant class of siRNAs (3, 4) that are almost exclusively
22 nt long and possess a guanine (G) as the 5= nucleotide; hence,
they are referred to as 22G RNAs. 22G RNAs are more abundant
than siRNAs produced by Dicer and are required for effective
gene silencing. However, they are not able to recruit RdRps to
the target and thus are unable to initiate the generation of
further 22G RNAs (5).
The exogenous RNAi pathway in C. elegans is systemic (6, 7).
Uptake of dsRNA into the intestine by the transporter protein
SID-2 and transfer between cells by SID-1 and SID-5 are capable
of silencing gene expression inmost tissues (8–11). The exact mo-
bile RNA species remains elusive, but there is some evidence to
suggest that dsRNA molecules (probably DCR-1 products) are
mobile and can be exported and imported by proteins required for
systemic RNAi (12).
Silencing initiated by the exogenous RNAi pathway can spread
not just within treated animals but also to their offspring inwhat is
known as transgenerational inheritance (13–16). Transgenera-
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tional inheritance initiated by RNAi does not occur at every locus
and is not fully penetrant; i.e., not all offspring inherit the silenced
phenotype. The mechanisms responsible for both the transmis-
sion and the establishment of transgenerational silencing remain
cryptic, although it seems that both small RNA pathways and
chromatin modifiers are required (13–18).
RNAi acts as a potent defense mechanism against viruses in
plants and animals (19–23). In plants, long viral dsRNA precur-
sors are processed into 21-nt-long siRNAs byDicer-like 4 (24, 25).
These 21-nt siRNAs are capable of moving from cell to cell and
directing silencing in the recipient cell (26, 27). The spread of
siRNAs ahead of viral infection confers resistance on recipient
cells. Twenty-four-nucleotide Dicer-like 3 products are also capa-
ble of systemic spreading (26, 28). Similarly, Drosophila also uti-
lizes a siRNA pathway in viral defense. In this case, both Dicer 2
and Argonaute 2 are required for an effective antiviral response
(29). Again, systemic spreading throughout the organism is im-
portant in antiviral immunity, although in this case it seems to be
dsRNA molecules that are mobile (29). RNAi pathways have also
recently been suggested to play a role in viral defense in mammals
(20, 21), although to date it is not known if the antiviral silencing
can spread between cells.
The RNAi pathway also acts in viral defense in C. elegans. The
initial trigger is a dsRNA viral replication intermediate that is rec-
ognized by DRH-1 (30). This recognition allows DCR-1 and ac-
cessory proteins to produce siRNAs and subsequently 22G RNAs
in a manner that appears to utilize the same pathway as classical
RNAi gene silencing (19, 30–32); indeed, our current knowledge
suggests that it is only the viral recognition factor DRH-1 that
differs between the two pathways.
Despite the similarities to the canonical RNAi pathway, it is
still unclear whether the C. elegans antiviral siRNA pathway
gives rise to systemic effects. In the case of a virus that infects
somatic cells, such as the Orsay virus, indirect evidence to sup-
port systemic antiviral RNAi could be taken from transgenera-
tional inheritance of silencing, since this implies that the RNAi
response must have spread into the germ line. Transgenera-
tional silencing of a Flock House virus transgene under the
control of a heat shock promoter has been observed (33); how-
ever, this may occur as a result of the presence of the transgene
in all of the cells of the animal. More recently, it was reported
that parental exposure to Orsay virus can protect offspring
from infection (34). However, Guo and colleagues reported
that the sid-1 mutant is no more susceptible to Orsay virus
infection than N2 is, suggesting that systemic RNAi is not im-
portant in viral defense (35).
In this study, we tested for the existence of a systemic RNAi
response against the Orsay virus by using a sensor for antiviral
siRNA to report on the spread of antiviral silencing between cells.
Surprisingly, in contrast to the exogenous RNAi pathway in C.
elegans and viral defense pathways in both plants and Drosophila,
we found that RNAi following infection with Orsay virus is not
systemic. Consistently, we found that there is no transgenerational
inheritance of Orsay virus-induced silencing. Together, these re-
sults suggest partitioning between intermediates in RNAi induced
by the Orsay virus and exogenous dsRNA and challenge the as-
sumption that systemic RNAi evolved as an antiviral defense
mechanism.
MATERIALS AND METHODS
Genetics. C. elegans was grown under standard conditions at 20°C on
HB101 bacteria unless otherwise indicated. The wild-type strain was var.
Bristol N2 (36). The strains used in this study were HC75 [ccIs4251 sid-
1(qt2)], HC271 [ccIs4251 qtIs3 sid-2(qt42) mIs11], RB2519 [drh-
1(ok3495)], SX2836 (mjIs242[psur-5::GFP::OrsayRNA2::tbb-2  psur-5::
mCherry::unc-54]), SX2839 {mjIs242[psur-5::GFP::OrsayRNA2::tbb-2 
psur-5::mCherry::unc-54] sid-1(qt2)}, SX2838 {mjIs242[psur-5::GFP::Or-
sayRNA2::tbb-2 psur-5::mCherry::unc-54] drh-1(ok3495)}, and SX2813
(mjEx565[psur-5::GFP::OrsayRNA1::tbb-2] mjEx566[psur-5::mCherry::
unc-54]).
Molecular biology. (i) Sensor generation. The psur-5::GFP::Orsay-
RNA2::tbb-2 and psur-5::GFP::OrsayRNA1::tbb-2 constructs were gener-
ated by using the MultiSite Gateway Three-Fragment Vector Construc-
tion kit (Life Technologies). psur-5 in the first position was a gift from the
Ahringer laboratory, and green fluorescent protein (GFP; cloned from
pPD95.75) was placed in the second position. PCR fusion was used to
generate the OrsayRNA::tbb-2 fragments that were placed in the third
position. All three fragments were combined in an LR reaction into the
pCFJ150 vector. The sequences of the primers used to amplify viral seg-
ments from cDNA are available on request.
(ii) Preparation of RNAi constructs.Viral segments were PCR ampli-
fied from cDNA by using primers with appropriate tails for BP cloning
into pDONR221 (Gateway cloning). LR reactions were performed to
place viral segments in a Gateway modified RNAi vector L4440. The se-
quences of the primers used are available on request.
Detection of viral infection. Virus filtrate was prepared as described
previously (19).
(i) Infection of strains of interest. For all strains, two or three young
adults were inoculated with 20 l of viral filtrate for 4 days at 20°C in
55-mm plates.
(ii) Detection of viral RNA. Four days after infection, all animals were
collected in M9; RNA extraction and quantitative reverse transcription
(qRT)-PCR was performed as described previously (19, 30). Aliquots of
RNA were kept apart for small RNA libraries (see below).
(iii) Comparison of infection methods. For liquid culture-based in-
fection, 200 L2 animals were rotated for 1 h at 20°C in 300 l of M9, 100
l of HB101 in LB broth, and 100l of Orsay virus filtrate (nondiluted or
diluted in M9 10 or 100 times). After 1 h, the animals were collected and
washed three times in M9 before transfer to 50-mm plates.
For agar-based infection, 200 L2 animals were transferred to a 50-mm
plate per individual infection. A 100-l volume of Orsay virus filtrate was
added (nondiluted or diluted in M9 10 or 100 times). Infections were
performed in five biological replicates.
For all strains, 200 L2 animals were infected and collected 48 h postin-
fection for detection of viral RNA as described above.
RNAi.RNAi bacteriawere grown for 6 hwith shaking at 37°C. Bacteria
were then seeded onto 55-mm nematode growthmedium plates contain-
ing isopropyl--D-thiogalactopyranoside (IPTG; 1mM) and carbenicillin
(25 g/ml). After drying overnight, two or three animals were added and
then grown at 20°C for 4 days, at which point they were collected for RNA
extraction (for measurement of Orsay viral loads or for small RNA se-
quencing) or their phenotype was scored (for the viral sensor experi-
ments). For the analysis of phenotypes of animals treated with RNAi
against the unc-22 (ZK617.1) or dpy-11 (F46E10.9) gene (37), four L4
animals were plated on RNAi plates (five replicates) against the relevant
gene and the progeny was grown on the same plates. Adult animals were
then transferred to non-RNAi plates, and the phenotype of the progeny
was scored to measure the percentage of animals displaying the pheno-
type. The experiment was repeated in triplicate.
SmallRNAsequencing. (i) RNAextraction, librarypreparation, and
sequencing. Extraction of RNA for libraries, library preparation, and se-
quencing were performed as described previously (30). P0 animals were
grown at 20°C on three 10-cm plates and collected as a mixed-stage pop-
ulation of predominantly adults 4 days after viral infection or RNAi treat-
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ment. F1 animals were obtained by bleaching of P0 animals and assayed at
three different ages—as embryos (immediate collection) and after 24 and
72 h. P0 infection was performed in biological duplicates, with one repli-
cate used for the embryos and the other used for both the 24- and 72-h
time points. P0 replicates were compared to ensure equality.
(ii) Sequencing analysis. Small RNA libraries were sequenced by us-
ing Illumina MiSeq and/or HiSeq. Processing and alignment of high-
throughput sequencing data to the Orsay virus were carried out as de-
scribed previously, by using Bowtie for all sequence alignments and
allowing up to one mismatch to compensate for divergence in the viral
sequence (30). To generate plots of small RNAs aligning to unc-22 and
dpy-11, coding sequences in fasta format for the dpy-11 and unc-22 genes
were downloaded from WormBase (WS236) and used to build genomes
with Bowtie-build to which small RNAs were aligned while allowing 0
mismatches.
Microarray data accession number. The raw high-throughput func-
tional genomics data obtained in this study are available under GEO ac-
cession number GSE60020.
RESULTS
Weak transgenerational transmission of antiviral siRNAs. Ex-
posing C. elegans to dsRNA through feeding, injection, or viral
infection results in the generation of two classes of siRNAs that
bring about RNAi (Fig. 1A). The members of the first class of
siRNAs are generated by DCR-1 activity on dsRNA, possess 5=
monophosphates, and have amodal length of 23 nt and no overall
first-nucleotide bias. The members of the second class of siRNAs
(22G RNAs) are generated by the activity of RdRp and have 5=
triphosphateswith a strong preference forG at the first nucleotide.
Standard small RNA library preparation cannot detect 22G RNAs
unless the 5= triphosphate is removed by enzymatic treatment.We
performed polyphosphatase treatment of the RNA before library
preparation, which enables the detection of both direct Dicer
products and 22G RNAs.
To better understand the antiviral RNAi response, we used
high-throughput sequencing to assess the small RNAs present in
biological duplicates of N2 animals infected with Orsay virus (N2
P0) and compared them with their uninfected offspring (N2 F1)
(Fig. 1B to E). As shown previously (30), the N2 P0 sample (Fig.
1B) shows Dicer products mapping both sense and antisense to
the viral genome and abundant 22G RNAs mapping antisense to
the viral RNA. There are considerably less viral interfering RNAs
(viRNAs) in F1 animals than in their parents and they decrease
over time (Fig. 1C to E and 2A).
To get an idea of how these very low levels of inherited viRNAs
compared to inheritance following exogenous RNAi, we also pre-
pared libraries from animals feeding on RNAi food against the
endogenous loci dpy-11 (Fig. 1F to I) andunc-22 (Fig. 1J toM) and
their offspring, which were fed standard HB101 bacteria. Both the
dpy-11 and unc-22 genes are expressed in somatic cells; however,
the dpy-11 phenotype conferred by RNAi can be inherited by the
F1 generation while the unc-22 phenotype cannot (Fig. 2B) (38).
siRNAs complementary to both dpy-11 and unc-22 were approx-
imately as abundant as viRNAs in infected P0 animals (Fig. 1F and
J). Both dpy-11 and unc-22 siRNAs were retained to considerably
higher levels than the viRNAs in the F1 offspring (Fig. 2A). Nota-
bly, 22G RNAs are still clearly visible in the offspring of both
unc-22 and dpy-11mutant-treated animals at all of the time points
sampled; dpy-11 22G RNA levels were higher than unc-22 22G
RNA levels, consistent with the inheritance of the dpy-11 pheno-
type. Thus, the viral siRNAs are inherited by the F1 generation at a
lower level than endogenous, somatically expressed loci, even
those for which a phenotype is not detected in the F1 generation.
No evidence of a protective “vaccination” effect in F1 ani-
mals. The fact that viRNAs appear to be inherited at such low
levels strongly suggested that they would be unable to protect the
F1 generation against future viral infection. To test this directly,
we grew wild-type animals in the presence or absence of virus,
“bleached” them to remove infected P0 animals and the Orsay
virus from the culture, and then reinfected the F1 generation. If
the small number of inherited viRNAs could protect the subse-
quent generation against viral infection, we would expect to see
lower levels of viral replication in the offspring of infected parents
than in uninfected parents. We detected viral loads in F1 animals
4 days after infection by quantitative PCR for Orsay virus RNA.
There was no difference in Orsay virus RNA levels between the
animals whose parents had been exposed to Orsay virus and those
with no prior exposure (Fig. 2C and D). These results suggest that
the few viRNAs detected in the F1 generation are insufficient to
induce viral silencing. This lack of F1 “vaccination” by the Orsay
virus contrasts with recently published work by Sterken et al. (34).
One main difference between the two studies is the infection pro-
cedure—infection in liquid culture for 1 h, followed by growth on
agar (Sterken), versus infection and growth on agar (this study). It
is plausible that liquid-based infection may result in higher levels
of viral infection and thus make F1 “vaccination” possible. To
address this issue, we tested the levels of infection produced by the
two methods in both N2 and drh-1 animals and found that agar-
based infection was more reproducible and resulted in higher lev-
els of infection than liquid culture-based infection over a range of
viral concentrations (Fig. 2E).
Generation of an antiviral 22G RNA sensor to detect viral
infection. To understand the reasons for the failure of viRNAs to
be inherited by the F1 generation, we developed a GFP sensor
capable of detecting antiviral 22GRNAs. The sensor consists of an
integrated, multicopy transgenic array of the ubiquitous sur-5
promoter driving GFP expression, followed by approximately 600
bp of OrsayRNA2 before the tbb-2 3= untranslated region (UTR)
(psur-5::GFP::OrsayRNA2::tbb-2). The animals also carry the
same promoter driving mCherry expression with an alternate 3=
UTR (psur-5::mCherry::unc-54) (Fig. 3A). In this system, unin-
fected animals should express bothGFP andmCherry, resulting in
“orange” animals. Upon Orsay virus infection, viRNAs produced
in the infected cells should silence the GFP transgene, resulting in
red cells. As RNAi is systemic in C. elegans, the mobile silencing
signal generated after or during the dicing of viral dsRNA should
spread systemically through the organism. When, in an unin-
fected cell, the mobile species encounters the mRNA produced
from the sensor transgene, the mobile signal should trigger the
production of 22G RNAs and silence the sensor (Fig. 3B).
GFP and mCherry expression in uninfected animals is ubiqui-
tous but predominately intestinal (Fig. 3C). To confirm that the
sensor is responsive to silencing in all cells, we performed RNAi
against GFP or against the OrsayRNA2 fragment. This treatment
silences the sensor robustly in all animals, with residual GFP ex-
pression in the pharynx only (the pharynx is known to be some-
what RNAi resistant) (Fig. 4), confirming that exogenous RNAi
silences this sensor systemically. Surprisingly, however, when we
exposed these sensor animals to theOrsay virus,GFP silencingwas
not observed systemically; although 40% of the animals displayed
Nonsystemic Antiviral RNAi in C. elegans
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FIG 1 Deep sequencing of viRNAs after Orsay virus infection and RNAi. (A) Cartoon showing the pathway of the 23-nt Dicer product and 22GRNAproduction
inC. elegans. (B toM) 5= independent small RNA sequencing of P0 and F1 animals after either Orsay virus exposure (B to E) or the RNAi treatment indicated (F
to M). P0 animals were assayed as a mixed-stage population of predominantly adults, and F1 animals were synchronized and assayed at three different ages as
indicated. Data are shown as sense or antisense and ordered according to the size of the RNA molecule. The values on the y axis are reads per million.
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at least one silenced intestinal cell, less than 3% failed to silence all
intestinal cells (Fig. 3D).
Orsay virus infection does not produce a mobile siRNA sig-
nal. Given the limited ability of the antiviral RNAi response gen-
erated against the Orsay virus to spread between cells, we hypoth-
esized that systemic RNAi may not be important in defending
against viral infection. Supporting this view, Guo et al. recently
reported results suggesting that, indeed, Orsay virus accumulated
to similar levels in N2 and a sid-1mutant (35). We confirmed this
result and additionally showed that sid-2 is dispensable for viral
defense (Fig. 5A). In order to further study the role of sid-1 in viral
defense, we assayed the siRNAs present in Orsay-infected animals
and their offspring by small RNA sequencing as described above
for N2 animals (Fig. 5B and C). We could detect no difference in
small RNAs between the sid-1mutant strain and N2, further con-
firming that sid-1 transport of mobile siRNAs is not required for
their generation in the context of Orsay virus infection.
If RNAi is notmoving fromcell to cell during infectionwith the
Orsay virus, cases where we observe sensor silencing in more than
one cell would occur only because the virus directly infects each
cell. To test this hypothesis, we crossed the sensor into the drh-1
mutant background, which displays increased susceptibility to vi-
ral infection (Fig. 6A). drh-1 mutant sensor animals displayed an
increased number of animals with many silenced cells (Fig. 6C),
FIG 2 No evidence of inheritance of viRNAs after Orsay virus infection. (A) The 23-nt sense (left) Dicer products and 22G antisense (right) secondary RNAs
from Fig. 1 normalized to library size and the level in the P0 generation. (B) Percentages of P0 and F1 animals displaying the dpy- or unc-encoded phenotype
following exposure to RNAi. Error bars show the standard deviation of three (P0) or four (F1) biological replicates. **, P 0.005; NS, not significant (t test). (C)
The experimental design for the data shown in panel D. (D) qRT-PCR data for the relative levels of Orsay virus 4 days after exposure in animals whose parents
were either infected with Orsay virus (VV) or uninfected (VV) (Orsay virus infection of parents was confirmed by qRT-PCR). Data are normalized to
gapdh levels and the level of infection of theVparents. Error bars show the standard error of themean. (E)Graph showing a comparison ofOrsay virus infection
levels between liquid- and agar-based infection protocols in both the drh-1mutant and N2 strains with three different concentrations of virus. Each condition
was performed with five biological replicates, and error bars represent the standard error of the mean.
Nonsystemic Antiviral RNAi in C. elegans
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suggesting that silencing of the sensor is driven by infection rather
than mobile RNAi. While drh-1 mutant animals are defective in
the production of antiviral siRNAs, they do produce them at low
levels (30), enough to silence the sensor in infected cells.
To test the lack of cell-to-cell spreading further, we crossed the
sensor into the sid-1mutant background. As the sid-1mutant is as
susceptible to viral infection as N2 is (Fig. 5A), there should be no
difference between the number of silenced cells within individual
animals between N2 and sid-1 mutant sensor animals. However,
whenwe crossed the sensor into sid-1mutants (Fig. 6B), there was
a significant difference between the numbers of animals withmul-
tiple silenced cells in the sid-1 mutant and N2 backgrounds
(Fig. 6C). This might indicate that a low level of spreading of
silencing from one cell to its direct neighbor does occur in N2. To
address this issue in all three strains, we monitored eight partially
silenced animals individually over 3 days and the GFP silencing
never became systemic (Fig. 7). Over the 3 days that wemonitored
the N2 and sid-1 mutant sensor animals, the number of GFP-
silenced cells rarely changed, indicating that if a silencing signal
passes from one cell to another, it happens very slowly or infre-
quently. In the drh-1 background, the number of silenced cells
increased in more than half of the animals over the 3-day period.
Although not significantly different from N2, this trend is consis-
tent with an increased number of infected cells due to the higher
levels of infection known to be sustained in this background (30).
Taken together, these results indicate that, unlike in exogenous
RNAi, viral infection does not result in large numbers of dsRNA
intermediates able to be trafficked by SID-1.
Orsay-derived transgenes are not sufficient to enable inher-
itance of antiviral siRNAs against the Orsay virus. The lack of
inheritance of the antiviral RNAi response against the Orsay virus
was surprising given that Flock House virus transgene silencing
was reported to be transgenerationally inherited (33). One expla-
nation for this discrepancy could be that the Flock House virus
transgene is carried in all cells, while the Orsay virus infects only
intestinal cells. Transgenerational silencing might therefore not
occur in the Orsay virus because there is a requirement for a tem-
plate, either RNA or DNA, in the germ line in order to transmit a
FIG 3 Development of a viRNA sensor. (A) Schematic of viRNA sensor. (B) Cartoon showing the expected phenotype of sensor animals in the absence of Orsay
virus (top) and in the presence of Orsay virus with (middle) or without (bottom) systemic silencing. Yellow indicates both GFP and mCherry expression. Red
indicates onlymCherry expression. (C)Orsay virus sensor showing representative uninfected (left) and infected (right) animals. Infected- anduninfected-animal
images were taken at the same intensity. (D) Percentages of sensor animals showing the amounts of silenced cells indicated in the absence (gray) or presence
(black) of Orsay virus. Error bars indicate the standard error of the mean of six biological replicates.
FIG 4 Orsay virus sensor with RNAi. The Orsay virus sensor shows represen-
tative animals treated with the RNAi clones indicated. All images were taken at
the same intensity.
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silencing signal. To test this, we asked whether Orsay virus infec-
tion could transmit silencing of the viral sensor transgene, carried
in all cells, to the next generation.
First, we tested whether RNAi induced silencing against either
GFP or theOrsayRNA2 fragment in the P0 generation could result
in transgenerational sensor silencing. We subjected P0 Orsay-
RNA2 sensor animals to RNAi treatment with either GFP or Or-
sayRNA2. Either treatment resulted in complete sensor silencing,
as described previously (Fig. 4). Adults were then removed from
the RNAi treatment, and the phenotype of the resultant F1 prog-
enywas scored after 4 days. Both treatments resulted in silencing
of the GFP transgene in the F1 generation (Fig. 8A), showing
that the sensor is capable of being silenced in a transgenera-
tional manner.
To test for transgenerational silencing of the sensor following
Orsay virus exposure, we scored the GFP status of the offspring of
eight animals that themselves displayed partial sensor silencing
(andwere thus infectedwithOrsay virus). Orsay virus is not trans-
mitted vertically (19), so the only virus present on these plates is
that carried by the parent. We performed this experiment in the
wild-type sensor and sid-1 and drh-1mutant genetic backgrounds.
The offspring of wild-type- and sid-1 mutant-infected parents
showed almost no GFP silencing (and were not significantly dif-
ferent from each other), whereas drh-1mutant F1 animals showed
significantly more GFP silencing than the wild-type sensor (P 
0.001) (Fig. 8B). These data are consistent with no inheritance of
transgene silencing following viral infection in any genotype and
horizontal transmission of viral infection and thus de novo sensor
silencing in the case of drh-1.
Noprotectionagainst infectionwith theOrsayvirus in theF1
generation followingRNAi.Wehave shown that exposure of par-
ents to the Orsay virus does not confer resistance in F1 progeny
FIG 5 sid-1 and sid-2 are not required for viral resistance. (A) qRT-PCR showing the relative levels of Orsay virus 4 days after infection in N2 and in drh-1, sid-1,
and sid-2 mutants. drh-1 mutant animals show significantly higher levels of Orsay virus RNA than N2 animals do (P 0.05, t test), but there is no significant
difference between either sid-1 or sid-2mutant andN2 animals. Data were normalized to gapdh and thenN2. (B) Shown are the 23-nt sense (left) Dicer products
and 22G antisense (right) secondary RNAs from panel C (sid-1) and Fig. 1 (N2) normalized to library size and the level in the P0 generation. emb, embryo. (C)
5= independent small RNA sequencing of P0 and F1 sid-1 mutant animals after Orsay virus exposure. P0 animals were assayed as a mixed-stage population of
predominantly adults, and F1 animals were synchronized and assayed at three different ages as indicated. Data are shown as sense or antisense and ordered
according to the size of the RNAmolecule. The values on the y axis are reads per million. The 5= nucleotide is indicated by color as follows: red, A; green, C; blue,
G; pink, U.
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FIG 6 Orsay virus sensor in the sid-1 and drh-1 mutant backgrounds. (A, B) Orsay virus sensor showing representative uninfected (left) and infected (right)
animals. Infected- and uninfected-animal images were taken at the same intensity. (C) Percentages of sensor N2 (light gray), sid-1 mutant (gray), and drh-1
mutant (black) animals showing the amounts of silenced intestinal cells indicated in the presence of Orsay virus. The amount of intestinal cell silencing differs
significantly between both the sid-1 and drh-1 mutant backgrounds and the wild-type background (P  0.001 [Fisher’s exact test] in both cases). Error bars
represent the standard error of the mean of six biological replicates.
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and that Orsay virus-induced sensor silencing does not seem to be
inherited. RNAi-induced silencing against the viral sensor can
however be passed on to the F1 generation; therefore, we asked
whether RNAi-induced silencing in the presence of the Orsay vi-
rus sensor could protect the P0 generation or F1 offspring against
Orsay virus infection.
We tested a series of regions of the Orsay virus RNA genome
for the ability to protect against Orsay virus replication in RNAi
feeding experiments (Fig. 8C). Intriguingly, Orsay virus levels
were affected more after RNAi against OrsayRNA1 than after
RNAi against OrsayRNA2 (Fig. 8D). This difference in RNAi effi-
cacy between RNA1 and RNA2 could be due to the fact that RNA1
encodes the RdRp and RNA2 encodes the capsid protein. RNAi
against the RdRp ismore likely to have a direct effect on viral RNA
accumulation within infected cells than RNAi against the capsid,
which is more likely to affect later steps of the viral life cycle such
as assembly.
We then asked whether there was also a reduction in Orsay
virus RNA levels following concurrent RNAi and viral infection in
N2 or an Orsay virus sensor background (Fig. 8E). Because viral
levels were most significantly altered in animals feeding on RNAi
clones targeting RNA1 rather than in animals feeding on RNAi
clones targeting RNA2, for this experiment, we used an Orsay-
RNA1 sensor instead of the previously used OrsayRNA2 sensor.
The sensor was extrachromosomal instead of integrated but oth-
erwise identically constructed. Interestingly, while Orsay virus
RNAi reduced the levels of Orsay virus RNA detected in N2, the
presence of the RNA1 sensor resulted in evenmore RNAi-induced
protection against Orsay virus replication (Fig. 8F). It is tempting
to speculate that this sensor-associated RNAi “boost” is due to the
presence of siRNAmolecules (generated from the sensor) already
in the cell before viral entry, thus enabling immediate viral RNA
destruction.
To test whether the combination of RNAi against the Orsay
virus and the sensor could confer protection on the F1 offspring,
we bleached the adults from the previous experiment to generate
uninfected embryos and then infected them with the Orsay virus
(Fig. 8E). Despite the large difference in Orsay virus infection
levels between RNAi-treated and nontreated sensor animals in the
P0 generation, there was no difference in the infection levels of
their offspring (Fig. 8G, gray). Therewas also no difference in viral
infection levels in the N2 F1 offspring of parents fed on either
empty or RNA1 interfering RNA (Fig. 8G, black).
These data show that even in the most extreme case of RNAi
and a transgenic viral portion, there is still no evidence of deposi-
tion in the F1 offspring of functional small RNA molecules that
can protect against Orsay virus infection.
DISCUSSION
Two of the most notable aspects of the siRNA pathway in C. el-
egans initiated in response to exposure to dsRNA matching en-
dogenous genes are its ability to spread throughout the animal and
its ability to act transgenerationally. There has been much specu-
lation onwhat the function of these properties is for animals in the
wild, with the proposed role of RNAi in antiviral silencing a key
candidate. Here we have shown that infection of C. elegans with
the Orsay virus instigates neither transgenerational nor systemic
silencing. In the absence of any other known naturally occurring
C. elegans virus, it is possible that systemic RNAi may function in
defense against an as-yet-undiscovered infection. Nevertheless,
our results have important implications for both the mechanism
of systemic RNAi and the biology of small RNA pathways in C.
elegans.
The fact that antiviral siRNA induced by Orsay virus infection,
in contrast to siRNA induced by exposure to dsRNA, does not
spread between cells may be explained by differences in the inter-
mediates produced by the two pathways. Importantly, 22G RNAs,
produced by both pathways, are unlikely to transfer RNAi in C.
elegans (12), perhaps because they cannot themselves trigger the
production of further 22GRNAs in somatic cells (5, 39).However,
there is evidence that a small RNA species generated by the activity
of Dicer/RDE-4 in response to dsRNA generated from endoge-
nous genes or taken up from the environment is able to spread
between cells (12). Both RDE-4 and Dicer are active on viral
dsRNA; thus, their activity must somehow be different when they
act on viral dsRNA rather than other sources of dsRNA. It is pos-
sible that this difference is due to the requirement of DRH-1 spe-
cifically for activity on viral dsRNA, perhaps reflecting a different
subcellular localization of the DRH-1/Dicer complex. An alterna-
tive possibility is that the Orsay virus itself prevents systemic
RNAi. Such a situation is well known to occur in plant viruses,
many of which encode suppressors of silencing that prevent cell-
FIG 7 No systemic sensor silencing following Orsay virus infection. Horizontal blocks indicate individual infected animals monitored for 3 days at 5 (black), 6
(light gray), and 7 (dark gray) days postinfection. The values on the x axis are the percentages of the animal silenced. Eight N2 (A), sid-1mutant (B), and drh-1
mutant (C) animals each were monitored.
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FIG 8 RNAi-induced Orsay virus silencing. (A) Graph showing the percentages of F1 animals with inherited sensor silencing after parental exposure by feeding
toRNAi against either the empty vector (black), GFP (light gray), orOrsayRNA2 (dark gray). Error bars represent the standard error of themean of two biological
replicates. (B) Sensor silencing in the F1 offspring of infected animals (as judged by sensor silencing). The values on the x axis are the percentages of N2 (light
gray), sid-1mutant (dark gray), and drh-1mutant (black) animals with the indicated amounts of sensor silencing in the intestine. ***, P 0.0005 (Fisher’s exact
test). (C) Cartoon showing the position on the Orsay virus genome of the RNAi clones used in panel D and the positions of the quantitative PCR (qPCR)
amplicons. (D)Graph showing the relative levels of Orsay virus (4 days postinfection)measured by qRT-PCR inN2 animals fed the RNAi clones indicated. Error
bars represent the standard error of the mean of 3 (R1-1, R1-2, R2-1), 6 (R1-3, R1-4, R2-2, R2-3), or 12 (empty) biological replicates. (E) Schematic illustrating
the experimental design used to test for the presence or absence of viral resistance in the F1 generation caused by previous viral exposure, viral RNAi, or both. (F)
Graph showing the relative Orsay virus levels measured by qRT-PCR in P0 animals 4 days after Orsay virus exposure. Animals were wild type or carried an
OrsayRNA1 sensor transgene and were exposed to either the empty vector or OrsayRNA1 RNAi. Exposure to Orsay virus RNAi in the P0 generation causes
resistance to Orsay viral infection in both genetic backgrounds, although the effect is more significant in the sensor background. Data were normalized to gapdh
and then the N2 empty vector. *, P 0.05; ***, P 0.0005 (t test). Error bars represent the standard error of the mean of three biological replicates. (G) Relative
OrsayRNA1 levels in F1 animals. The x axis shows the RNAi treatment and/or Orsay exposure of their parents. N2 animal are shown in black, and RNA1 sensor
animals are in light gray. There is no significant difference in any treatment or strain. Data were normalized to gapdh and then theN2 F1 empty vector. Error bars
represent the standard error of the mean of three biological replicates.
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to-cell spreading of silencing (40). Further work is required to
distinguish between these two possibilities.
Our observations on the nonsystemic nature of the antiviral
RNAi response to infection with the Orsay virus are fully consis-
tent with the facts that we detected no transgenerational protec-
tion against infection and did not detect a strong small RNA signal
mapping to the virus in the embryos derived from infected indi-
viduals. This is in contrast to the robust inheritance of both small
RNAs and the silencing phenotype in the case of RNAi-induced
silencing of the dpy-11 gene and inheritance of small RNAs, albeit
without an observable phenotype, in silencing of the unc-22 gene.
The lack of systemic RNAi after infectionwith theOrsay virus thus
prevents small RNAs from entering embryos to a sufficient extent
to transmit the silencing effect.
The function of RNAi in antiviral defense in plants, fungi, and
animals, including mammals, has led to the proposal that viral
infection was the major driving force behind its evolution. Sys-
temic silencing, which potentially allows antiviral siRNAs tomove
ahead of the spread of virus, and transgenerational vaccination of
the next generation might seem to be ideal components of an
effective antiviral pathway. It is therefore interesting that neither
of these two aspects of theC. elegansRNAi pathway is employed in
targeting theOrsay virus, despite an absolute requirement for cell-
autonomous RNAi in antiviral defense. It remains possible that
other naturally occurring viruses will be discovered that can insti-
gate systemic or transgenerational responses, in particular, viruses
that could infect the germ line or DNA viruses, which, in plants,
appear to be targeted by transgenerational silencing through
RNA-directed DNA methylation. It is also possible that, as noted
above, theOrsay virus itself has evolved to prevent systemic silenc-
ing, although it is worth noting that RNAi-competent strain N2 is
unlikely to be the natural host of the Orsay virus. The Orsay virus
was discovered in strain JU1580, which is deficient in antiviral
RNAi (19, 30); thus, there may not have been strong selective
pressure to evolve resistance to systemic silencing in this virus.
However, it remains an interesting possibility that systemic RNAi
in C. elegans evolved for completely different reasons, linked po-
tentially to its unusual ability to take up dsRNA from its environ-
ment. The answers to these questions require deeper sampling of
C. elegans in its natural environment to understand better the
selective forces acting on the RNAi pathway in the wild.
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